| Name: | 1-(But-3-en-1-yl)-4-(2,3-dichlorophenyl)piperazine |
| Catalogue No. | VE008723 |
| CAS No. | 1424857-93-1 |
| Molecular Formula | C14H18Cl2N2 |
| Molecular Weight | 285.21 g/mol |
| Status | In-Stock |
| IUPAC Name | 1-(But-3-en-1-yl)-4-(2,3-dichlorophenyl)piperazine |
| Description | 1-(But-3-en-1-yl)-4-(2,3-dichlorophenyl)piperazine CAS No: 1424857-93-1 is an impurity of Aripiprazole which is prescribed alone or together with other medicines to treat mental conditions like bipolar I disorder (manic-depressive illness), major depressive disorder, and schizophrenia. It is also prescribed to children to treat irritability associated with autistic disorder and Tourette syndrome. Its an antipsychotic agent |
| References | “Aripiprazole (Oral Route) Side Effects - Mayo Clinic.” Mayoclinic.org, 2015, www.mayoclinic.org/drugs-supplements/aripiprazole-oral-route/side-effects/drg-20066890?p=1. |
![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/thumb_aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)